|
|
Article: COPD PATIENTS ACHIEVE BETTER LUNG FUNCTION WITH SPIRIVA AND FORMOTEROL: STUDY.
- Article from:
- AsiaPulse News
- Article date:
- September 19, 2005
CopyrightCOPYRIGHT 2005 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(Full text of statement. Contact details below.)
COPENHAGEN, Sept. 18 /PRNewswire-AsiaNet/ --
First Prospective Study to Evaluate the Use of Two Long-Acting Bronchodilators Versus a Long-Acting Bronchodilator and an Anti-Inflammatory
Patients with Chronic Obstructive Pulmonary Disease (COPD) achieved superior lung function improvements when treated with the free combination of two bronchodilators with different modes-of-action, Spiriva(R) (tiotropium) and formoterol, compared with the free combination of one bronchodilator, salmeterol, and an anti-inflammatory, fluticasone propionate, according to the results of a study presented today at the ...